USP should be fine [Dissolution / BCS / IVIVC]

posted by Helmut Homepage – Vienna, Austria, 2019-10-25 00:33  – Posting: # 20726
Views: 561

Hi John,

» For ANDA, if the dissolution method for a drug product does not exist in the FDA dissolution database but exists in the USP dissolution database, the USP method is acceptable right?

Yep.

» We've done this before and never had issue from the FDA. Just want know if anyone has experienced push back before.

Two slides of Malcolm Ross (Athens, last November).

[image]

[image]


However, commonly it is the other way ’round. The USP adds methods once they are published in an NDA or ANDA. Malcolm has decades of experience with the FDA… I’ll meet him again in two weeks. Will ask whether he is aware of any problems.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
20,343 posts in 4,272 threads, 1,401 registered users;
online 6 (1 registered, 5 guests [including 2 identified bots]).
Forum time (Europe/Vienna): 03:28 CET

That which is static and repetitive is boring.
That which is dynamic and random is confusing.
In between lies art.    John Locke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5